Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Stefan Lanker"'
Autor:
Jiwon Oh, Laura Airas, Daniel Harrison, Elina Järvinen, Terrie Livingston, Stefan Lanker, Rayaz A. Malik, Darin T. Okuda, Pablo Villoslada, Helga E. de Vries
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
Key unmet needs in multiple sclerosis (MS) include detection of early pathology, disability worsening independent of relapses, and accurate monitoring of treatment response. Collaborative approaches to address these unmet needs have been driven in pa
Externí odkaz:
https://doaj.org/article/87221791cd044fc7bb3d3ea96d8fff84
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e70954 (2013)
Natalizumab inhibits the transmigration of activated T lymphocytes into the brain and is highly efficacious in multiple sclerosis (MS). However, from a pharmacogenomic perspective, its efficacy and safety in specific patients remain unclear. Here our
Externí odkaz:
https://doaj.org/article/33da09d155ec4c5d94663473815111fd
Autor:
Janna La Rue, Stefan Lanker, Keiko Nakayama, Kevin M. Friedman, Catherine Berset, Dong-Er Zhang, Sara A. Tokarz, Keiichi I. Nakayama
Publikováno v:
Journal of Biological Chemistry. 279:46424-46430
The Skp2 oncoprotein belongs to the family of F-box proteins that function as substrate recognition factors for SCF (Skp1, cullin, F-box protein) E3 ubiquitin-ligase complexes. Binding of the substrate to the SCFSkp2 complex catalyzes the conjugation
Publikováno v:
Molecular and Cellular Biology. 22:4463-4476
Degradation of Saccharomyces cerevisiae G(1) cyclins Cln1 and Cln2 is mediated by the ubiquitin-proteasome pathway and involves the SCF E3 ubiquitin-ligase complex containing the F-box protein Grr1 (SCF(Grr1)). Here we identify the domain of Cln2 tha
Autor:
Curt Wittenberg, E.Elizabeth Patton, Stefan Lanker, Brandt L. Schneider, Bruce Futcher, Mike Tyers, Michael D. Mendenhall
Publikováno v:
Nature. 395:86-89
In most eukaryotes, commitment to cell division occurs in late G1 phase at an event called Start in the yeast Saccharomyces cerevisiae, and called the restriction point in mammalian cells. Start is triggered by the cyclin-dependent kinase Cdc28 and t
Autor:
Ghazal Banisadr, Joseph R. Podojil, Stefan Lanker, Linda A. Piccinini, Stephen D. Miller, Samantha R. Schwartz, Richard J. Miller
Publikováno v:
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. 9(3)
Excessive infiltration of leukocytes and the elaboration of inflammatory cytokines are believed to be responsible for the observed damage to neurons and oligodendrocytes during multiple sclerosis (MS). Blocking adhesion molecules or preventing the ef
Publikováno v:
Science. 271:1597-1601
Cyclins regulate the major cell cycle transitions in eukaryotes through association with cyclin-dependent protein kinases (CDKs). In yeast, G1 cyclins are essential, rate-limiting activators of cell cycle initiation. G1-specific accumulation of one G
Publikováno v:
Cell. 70:647-657
We cloned the GCD5 gene of S. cerevisiae and found it to be identical to KRS1 , which encodes lysyl-tRNA synthetase (LysRS). The mutation gcd5-1 changes a conserved residue in the putative lysine-binding domain of LysRS. This leads to a defect in lys
Autor:
Halina Offner, Susan Goelz, Arthur A. Vandenbark, Jianya Huan, Stefan Lanker, Dorian La Tocha, Marisa Agotsch, Dennis Bourdette
Publikováno v:
Journal of neuroimmunology. 215(1-2)
Disease modifying effects of interferon (IFN)-beta therapy in patients with multiple sclerosis (MS) may be mediated in part through enhanced immunoregulation by the CD56(bright) subpopulation of natural killer (NK) cells and by Foxp3+ (not italicized
Autor:
Stefan Lanker, Julien P. Fey
Publikováno v:
Yeast (Chichester, England). 24(5)
The ability to integrate nutrient availability into cell cycle regulation is critical for the viability of organisms. The Saccharomyces cerevisiae ubiquitin ligase SCF(Grr1) regulates the stability of several proteins that participate in cell divisio